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ABSTRACT
The primary objective of this study was to evaluate the synergistic effects of repeated sprint
training in hypoxia (RSH) and beta-alanine supplementation on performance in recreationally
active men. Participants were randomly assigned to one of the following groups: hypoxia + betaalanine (HB, n = 10), hypoxia + placebo (HP, n = 9), normoxia + beta-alanine (NB, n = 11) and
normoxia + placebo (NP, n = 8). All participants completed a total of 8 training sessions (each
consisting of 3 sets of 5 × 10-s sprints at a resistance of 7.5% of body mass, with 20-s rest
intervals between sprints) over 4 weeks on a cycle ergometer either in hypoxia (Oxygen fraction:
FiO2 = 14.2%) or normoxia (FiO2 = 20.9%). Participants were instructed to consume a daily
dosage of 6.4g (two 800 mg tablets ingested 4 times per day at 3-4 hour intervals) of either betaalanine or placebo. Changes in performance in a graded exercise test (GXT), repeated sprint test
(RST) and 3-min all-out test (3MT) were examined before and after 28-days of training and
supplementation. Aerobic performance was measured by maximal oxygen consumption
(VO2max), peak power output (PPO). Exercise intolerance was assessed from critical power
(CP), oxygen consumption (VO2RCP) and power output (PRCP) at respiratory compensation
point. Exercise capacity was measured by total work (TW) during 3MT. Anaerobic capacity was
evaluated via anaerobic working capacity (AWC), heart rate response to RST (RST_HR60) and
lactate responses to RST (RST_La) and 3MT (3MT_La). Repeated sprint performance was
estimated through average power output of the last sprint (RST_AP5) and all sprints (RST_AP).
No between-group differences were observed for training volume or supplementation
compliance. Anthropometric and hematological measures remain unchanged before and after
intervention in all groups. A main effect of altitude was shown for VO2RCP, PRCP, RST_AP5,
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RST_HR60, and TW, with post-intervention values in the hypoxia groups significantly (p <
0.05) higher (lower for RST_HR60) than the normoxia groups. A main effect of beta-alanine was
detected in AWC, with post-intervention values in the beta-alanine groups being significantly (p
< 0.05) higher than the placebo groups. Results of this investigation demonstrated that RSH and
beta-alanine benefit performance from different perspectives. RSH improved aerobic
performance, exercise tolerance, cardiovascular recovery and exercise capacity, while betaalanine supplementation maintained anaerobic working capacity in recreationally-trained men
during the four-week repeated sprint training intervention.
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CHAPTER ONE: INTRODUCTION
Muscle buffering capacity is a key mechanism related to high intensity exercise
performance. Skeletal muscle acidosis impedes several metabolic processes, and as a result,
force production is reduced (Spriet, Lindinger, McKelvie, Heigenhauser, & Jones, 1989). These
processes include the disruption of phosphocreatine (PCr) resynthesis, inhibition of glycolysis,
and dysfunction of the muscle contractile machinery (Hobson, Saunders, Ball, Harris, & Sale,
2012). Muscle buffering capacity derives from several physiological buffers, such as proteins,
inorganic phosphate, bicarbonate, and the histidine-containing dipeptide carnosine (Parkhouse &
McKenzie, 1984). In humans, carnosine contributes 7-8% of total muscle buffering capacity
(Harris, Marlin, Dunnett, Snow, & Hultman, 1990; Hill et al., 2007; Mannion, Jakeman, Dunnett,
Harris, & Willan, 1992). Due to the importance of buffering capacity on anaerobic exercise
performance, many training programs and dietary supplementation strategies have been focused
on elevating muscle buffering capacity and improving anaerobic performance.
Altitude and simulated altitude training has been used in the pursuit of performance
enhancement when returning to sea level for many years (Millet, Roels, Schmitt, Woorons, &
Richalet, 2010). This type of training has been implemented in a variety forms, including live
high-train high (LHTH), live high-train low (LHTL), and live low-train high (LLTH). More
specifically, LLTH is usually incorporated with intermittent hypoxic training (IHT).
Traditionally, it is has been hypothesized that endurance athletes benefited from LHTH or LHTL
owing to an increase in hematological capacity (Levine & StrayGundersen, 1997). However,
other factors such as muscle buffering capacity also play a significant role (Gore, Clark, &
Saunders, 2007). Performance benefits and associated mechanisms of LHTH have been
1

discussed thoroughly in several review articles (Bailey & Davies, 1997; Fulco, Rock, &
Cymerman, 2000; Millet et al., 2010). More recently, interest has focused on the potential of
repeated sprint training in hypoxia (RSH), which combines repeated sprint training and
intermittent hypoxic training. The advancement and development of hypoxic technologies have
made RSH more convenient and affordable (Girard, Brocherie, & Millet, 2013).
Several studies have demonstrated the effectiveness of RSH (Faiss et al., 2013b; Galvin,
Cooke, Sumners, Mileva, & Bowtell, 2013; Puype, Van Proeyen, Raymackers, Deldicque, &
Hespel, 2013). RSH is based on the repetition of ‘all-out’ efforts of short (≤ 30-second) duration
activity interspersed with brief incomplete recoveries (Girard, Mendez-Villanueva, & Bishop,
2011). This model differs from standard IHT due to its use of maximal intensity as the training
stimulus, which relies heavily on the recruitment of fast-twitch (FT) muscle fibers recruitment
under hypoxic conditions (Hautier, Linossier, Belli, Lacour, & Arsac, 1996). Millet and Faiss
(2012) reported that mRNA genes for oxygen signaling, oxygen carrying capacity, and pH
regulation were up-regulated, whereas mRNA genes involved in mitochondrial biogenesis were
down-regulated, reflecting more effective recruitment of FT fibers and the anaerobic energy
system following RSH. The advantage of RSH over IHT can be further explained by the greater
fractional oxygen extraction from tissue due to decreased oxygen delivery during exercise
(McDonough, Behnke, Padilla, Musch, & Poole, 2005). Holliss, Fulford, Vanhatalo, Pedlar, and
Jones (2013) reported that the addition of a hypoxic stimulus to training modulates
phosphocreatine resynthesis during exercise. Furthermore, Calbet and Lundby (2009) suggested
that RSH promotes the utilization of a “functional reserve in the muscle oxygen diffusing
capacity”. Thus, RSH has the potential to stimulate beneficial adaptations in terms of PCr
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resynthesis and oxygen utilization mediated by hypoxia-inducible factors in skeletal muscle
(Faiss et al., 2013b).
In addition to a well-designed and efficacious training program, the appropriate
consumption of dietary nutrients is of vital importance to maintain optimal training and
maximize competitive performance. Beta-alanine is commonly employed as an ergogenic aid
(Artioli, Gualano, Smith, Stout, & Lancha, 2010; Derave, Everaert, Beeckman, & Baguet, 2010;
Sale, Saunders, & Harris, 2010) and has been identified as the rate-limiting precursor to
carnosine which acts as a physiological buffer (Dunnett & Harris, 1999). Elevating muscle
carnosine enhances the intracellular buffering system, attenuating fatigue (Abe, 2000).
Numerous studies have demonstrated the effectiveness of beta-alanine supplementation on
improving muscle carnosine content (Baguet, Bourgois, Vanhee, Achten, & Derave, 2010;
Derave et al., 2007; Hill et al., 2007; Hoffman et al., 2015a; Stellingwerff, Decombaz, Harris, &
Boesch, 2012), which may improve performance during high intensity intermittent exercise.
However, most studies have focused on prolonged high intensity exercises, and relatively little is
known regarding the potential for ergogenic aids, especially with prescribed training programs,
to improve physiological and performance responses to multi-effort, short-duration exercises
such as repeated sprint training.
Of particular interest is whether the integration of RSH and beta-alanine supplementation
is superior to each intervention by itself, in regards to improving exercise performance during
various testing modalities. Saunders, Sale, Harris, and Sunderland (2014) examined the effects of
beta-alanine supplementation on an acute RSH protocol and found no differences in performance
when compared to placebo. Moreover, a recent study demonstrated that combining sprint interval
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training in hypoxia and nitrate ingestion increased the proportion of type IIa fibers in muscle,
which may contribute to enhanced 30s Wingate performance (De Smet et al., 2016). However,
there were several methodological limitations associated with these studies. Saunders et al.
(2014) did not include any type of hypoxic training, but only examined intermittent exercise
performance in hypoxia. De Smet et al. (2016) failed to blind the participants for
normoxia/hypoxia conditions and employed inappropriate statistical procedures. It can be
concluded from previous studies that RSH primarily enhances metabolic reactions involved with
pH regulation and glycolysis (Faiss et al., 2013b), while the most likely mechanism of action of
beta-alanine supplementation is to increase intracellular buffering capacity (Hoffman, Stout,
Harris, & Moran, 2015b). Therefore, the combination of RSH and beta-alanine supplementation
may provide independent but additive ergogenic effects on muscle buffering capacity through a
variety of potential mechanisms and has yet to be evaluated with regard to exercise performance.
Considering the lack of research examining the interaction between RSH and beta-alanine
supplementation, the purpose of this study was to examine the effects of RSH and beta-alanine
supplementation on aerobic, anaerobic, and repeated sprint performance in recreationally trained
men.
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CHAPTER TWO: LITERATURE REVIEW
Acute Effects of Repeated Sprint Training in Hypoxia
Several investigations have compared acute and training-induced responses to repeated
sprint training in hypoxia (RSH) and normoxia (RSN) on performance enhancement, endocrine
function, metabolic stress, and immune function (Alvarez-Herms, Julia-Sanchez, Gatterer,
Viscor, & Burtscher, 2015; Billaut & Buchheit, 2013; Billaut et al., 2013; Born et al., 2016;
Bowtell, Cooke, Turner, Mileva, & Sumners, 2014; Brickley, Hodkinson, & Hortal, 2014;
Girard, Brocherie, & Millet, 2016; Goods et al., 2016; Kon, Nakagaki, Ebi, Nishiyama, &
Russell, 2015; Morrison, McLellan, & Minahan, 2015) Various modes of exercise, such as
cycling, running, swimming and skiing were used in these studies. A comprehensive analysis of
the acute effects of repeated sprint training in hypoxia is provided below.
Performance responses
Bowtell et al. (2014) examined the acute physiological and performance responses to
repeated sprints on a non-motorized treadmill with varying levels of inspired oxygen fraction
(12.0%, 13.0%, 14.0%, 15.0%, 21.0%) in well-trained athletes. Increased heart rate, minute
ventilation, blood lactate, and muscle deoxygenation, together with decreased blood oxygen
saturation, pulmonary oxygen uptake and muscle recruitment were observed under all hypoxic
conditions. As for performance, peak running speed was well maintained in hypoxia, while
fatigue index and speed decrements were significantly greater in only the 12.0% vs 21.0%
comparison. These findings were supported by Girard et al. (2016), who assessed neuromuscular
changes during knee extension after repeated treadmill sprints in normoxia, moderate (16.8% O2)
and severe (13.3% O2) hypoxia. In this study, a larger sprint decrement score and a shorter
5

cumulative distance covered was only noted under severe hypoxia, but not moderate hypoxia,
when compared to normoxia. Furthermore, post-sprint reduction in isometric maximal voluntary
contraction was greater in severe hypoxia compared to normoxia. However, post-sprint
alterations in the rate of torque development were similar among the three conditions examined.
Peak and mean power output have been reported to be significantly lower in the last two
out of three sets during repeated sprints when performed in hypoxia (14.5% O2) compared to the
same training session performed in normoxia (Goods et al., 2016). Moreover, blood lactate
increased significantly after the training sessions, but no group difference was observed. This is
in accordance with a previous study (Brickley et al., 2014), which revealed similar blood lactate
concentrations after a single session of repeated cycling sprints performed in hypoxia (14.2% O2)
and normoxia. The authors also reported that critical power, but not repeated sprint performance,
was reduced after RSH when compared with RSN. Likewise, Alvarez-Herms et al. (2015)
reported that both blood lactate (measured immediately after exercise) and creatine kinase
(measured 24 hours after exercise) were similar among normoxia, and both moderate and severe
hypoxia conditions. They also reported that neither moderate nor severe hypoxia affected
jumping performance after six sets of 15s all-out consecutive jumps. In contrast, Morrison et al.
(2015) reported that blood lactate was significantly higher after repeated running sprints in
hypoxia than normoxia. The results of their investigation also indicated that hypoxia impaired
the average acceleration in set four, and peak speed and running distance during the last two out
of four total sets of running sprints.
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Physiological responses
Kon et al. (2015) examined the acute hormonal and metabolic responses to repeated
cycling sprints under different simulated altitudes. Glucose, free fatty acids, blood lactate,
growth hormone, epinephrine, norepinephrine, and insulin concentrations were evaluated before
and 15 min after hypoxia exposure, as well as before and up to 180 min after exercise performed
in hypoxia. The results demonstrated that all endocrine and metabolic measures increased
significantly after exercise without any between-group differences. However, when performing
area under the curve analysis, all-out sprints under severe normobaric hypoxia (13.6% O2)
induced greater elevation in circulating growth hormone, when compared to moderate hypoxia
(16.4% O2) and normoxia. The investigators also suggested that the elevated growth hormone
may contribute to the increase of free fatty acids observed in circulation after these sprints. Born
et al. (2016) examined a group of competitive cross-country skiers and assessed the circadian
variation of biomarkers of mucosal immune function, together with mood, in response to an
acute session of repeated double-poling sprints performed under normoxic or hypoxic conditions.
Similar responses were noted between the experimental conditions. Furthermore, Goods et al.
(2016) investigated the acute oxidative stress (F2-Isoprostane) and inflammatory (interleukin-6)
responses to a single session of repeated running sprints in hypoxia (14.5% O2) in Australian
footballers. They reported that repeated sprint training at simulated altitude induced greater
inflammation at 60-min after exercise than the same training session performed at sea level.
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Training Adaptations to Repeated Sprint Training in Hypoxia
With the advancement and development of simulated hypoxic devices, the ‘live low-train
high’ methods have become more convenient and affordable. Particularly, the combination of
repeated sprint training and intermittent hypoxic training has received considerable attention.
Several recent studies compared the effects of RSH and RSN on various testing modalities,
including those related to aerobic, single-effort, and repeated-effort performance. In a newly
published meta-analysis, Brocherie, Girard, Faiss, and Millet (2017a) concluded that RSH
improved average repeated sprint performance to a significantly greater extent than RSN.
Though not significant, additional beneficial effects on the best repeated sprint performance
during a given session and maximal oxygen consumption were also reported after RSH. The
following section contains primarily contemporary studies (see Table 1) while providing a brief
review on the effects of RSH on three main performance aspects related to aerobic, anaerobic,
and repeated sprint abilities. Furthermore, physiological mechanisms that may mediate the
adaptations to exercise performance are also summarized.
Training programs
RSH is characterized by the repetition of several short all-out efforts in simulated or
natural altitude environments interspersed with incomplete recoveries (Faiss, Girard, & Millet,
2013a). Reflective of the heterogeneity of participants recruited, various training programs have
been employed to accommodate differences related to sporting environment (soccer, rugby,
cycling, skiing, field hockey, Australian football), training status (untrained, recreationallytrained, and well-trained), and gender (women, and men). Generally, the duration of RSH
interventions ranged between two to five weeks with training frequencies of two to three sessions
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per week. However, training protocols differ considerably with regard to modality
(overground/treadmill running, cycling ergometer, double-poling ergometer, swimming), sprint
times (5-25 s efforts), as well as recovery time within sets (20-45 s) and between sets (5-10 min).
As for the environment, RSN is usually conducted at sea level with an O2 concentration around
20.9%, while the O2 concentration for RSH ranged from 13.0% to 14.8%, to simulate altitudes
between 2,500 and 3,500 m. Most studies chose SpO2 and heart rate, which serves as a reflection
of training intensity, to monitor training response for RSH and RSN.
Aerobic performance
Aerobic performance can be assessed using both laboratory-based (graded exercise
testing with gas analysis) and field-based (expressed as total distance or work rates)
measurements. Regarding field-based measure, RSH has shown to result in significantly greater
improvements in the Yo-Yo intermittent recovery (YYIR) test than RSN (Galvin et al., 2013).
However, Gatterer et al. (2015) found that microcycles of maximal shuttle running at simulated
altitude and sea level improved YYIR performance to the same extent. This is in accordance with
Faiss et al. (2015b), who reported that no differences in mean power output during a sportspecific aerobic test were found between RSH and RSN. Faiss et al. (2013b) indicated that
average power output during the three-minute all-out test remained unchanged from pre to post
in RSH and RSN. Kasai et al. (2015) found that time to exhaustion, but not maximal oxygen
consumption, had a greater increase in RSH compared to RSN in collegiate female athletes. In
contrast, Montero and Lundby (2016) reported no additional impact of RSH on endurance
performance, as determined by an incremental exercise test and time to exhaustion trials, at sea
level in endurance-trained participants. Hamlin, Olsen, Marshall, Lizamore, and Elliot (2017)
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also found that YYIR performance was improved throughout the post-training period following
both RSH and RSN without any between-group differences. Brocherie, Girard, Faiss, and Millet
(2015a) reported that maximal aerobic speed remained unchanged after RSH and RSN in youth
soccer players. In another study, Brocherie et al. (2015b) combined RSH and RSN with
traditional live-high train-low methods and reported similar improvement in YYIR performance
immediately, and three weeks following intervention.
Anaerobic performance
The effects of RSH and RSN on anaerobic performance, such as vertical jump, isometric
strength and isokinetic power, has been relatively under-investigated. Due to the recruitment of
fast-twitch muscle fibers to meet the neuromuscular demand during RSH (Buchheit & Laursen,
2013a, 2013b), adaptations in short-duration, single-effort performance would be expected.
Surprisingly, only a limited number of studies have examined this issue. Faiss et al. (2013b)
reported that both RSH and RSN improved 10s single sprint and 30s Wingate performance with
no differences between experimental conditions. Brocherie et al. (2015a) found that
countermovement jump and sprint performance improved similarly between RSH and RSN,
while the best and mean repeated agility time decreased to a greater extent in RSH than RSN. A
study by Gatterer et al. (2015) also demonstrated identical change in long jump performance
between running-based RSH and RSN.
Repeated sprint ability
Galvin et al. (2013) found that RSH training tended to result in greater distance covered
with a smaller speed decrement and greater ventilation compared to RSN during repeated sprint
testing. Similarly, Kasai et al. (2015) examined the effects of RSH and RSN on repeated sprint
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performance in women and reported that RSH showed significantly greater improvement in
repeated sprint performance than RSN. In addition, Faiss et al. (2013b) stated that the average
power of all sprints during repeated sprint ability (RSA) testing increased to the same extent in
RSH and RSN. Nevertheless, the number of sprints prior to exhaustion was extended only after
RSH, but not RSN. However, not all studies have shown beneficial effects of RSH with respect
to RSN. Lundby and Robach (2016) first questioned the study by Faiss et al. (2013b) pertaining
to the approach used to determine exhaustion, and later reported no difference between RSH and
RSN in regards to RSA performance enhancement (Montero & Lundby, 2016). It is worth
mentioning that participants in this study (Montero & Lundby, 2016) performed 12 different tests
within three days following the intervention period. Therefore, such a condensed schedule may
have induced residual fatigue while potentially confounding the training adaptations from RSH
and RSN (Millet, Brocherie, Faiss, & Girard, 2017).
As discussed elsewhere (Brocherie et al., 2017a), the exercise modality used to examine
RSH and RSN has not been limited to cycling. Faiss et al. (2015b) extended RSH to crosscountry skiing, and their results indicated that RSH resulted in the completion of more sprints
exceeding 70% of peak power. In a study by Trincat, Woorons, and Millet (2016), 16
competitive swimmers completed six training sessions of either RSH or RSN over two weeks.
RSA was tested before and after the intervention via 25m all-out sprints with 35s rest until
volitional fatigue. The results demonstrated a greater increase in maximal blood lactate
concentration in and a greater number of sprints completed in RSH than in RSN. Though
underpowered, Gatterer et al. (2014) first introduced soccer specific shuttle-run sprint training in
a simulated altitude and reported that RSH elicited a lower fatigue slope than RSN in a group of
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youth male soccer players. A follow-up study in adult male soccer players found a small effect
of hypoxia training for RSA performance when compared with training performed at sea level
(Gatterer et al., 2015). Brocherie, Millet, and Girard (2016) compared physiological and
perceptual responses to six sessions of running-based RSH and RSN over two weeks in field
hockey athletes. Results indicated that changes in heart rate were similar between the hypoxic
and normoxic conditions; however, ratings of overall perceived discomfort, difficulty breathing
and lower-limb discomfort were higher after the first session and reduced to a larger extent
during subsequent sessions in RSH compared to RSN. Recently, Hamlin et al. (2017)
demonstrated similar RSA performance improvement after three weeks of RSH and RSN with
only RSH maintaining improved RSA performance two weeks following the intervention Thus,
RSH may have long-lasting beneficial effects compared to RSN. This is partially in line with
Brocherie et al. (2015b), who combined a traditional hypoxia exposure protocol with RSH or
RSN and reported both immediate and extended RSA performance improvement after RSH.
More specifically, RSA improvement was twice as large in RSH than RSN and was well
maintained for three weeks after the intervention.
Potential physiological mechanisms
The beneficial effects of RSH are generally believed to be the result of a hypoxia-induced, nonhematological molecular regulation, mediated by hypoxia inducible factor-1α subunit (HIF-1α),
within skeletal muscle. HIF-1α is an oxygen sensitive transcriptional activator that stabilizes in
the nucleus in low oxygen fraction environments (Wang & Semenza, 1995). It has been
previously reported that HIF-1α controls the expression of a series of hypoxia-induced genes in
response to decreased oxygen availability (Semenza, Shimoda, & Prabhakar, 2006). Faiss et al.
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(2013b) reported that RSH resulted in higher mRNA expression of factors related to pH
regulation and glycolysis, and a greater downregulation of factors involved in mitochondrial
biogenesis, than RSN. Their findings suggested a potential enhancement of glycolytic
metabolism in muscle. In a more recent study, Brocherie et al. (2017b) examined whether RSH
induces greater beneficial adaptations in HIF-1α pathway and its target genes than RSN, when
combined with chronic hypoxic exposure. Muscle biopsies were obtained before, immediately
after, and three weeks of the intervention. Compared to RSN, RSH elicited greater increases in
mRNA levels related to the regulation of oxygen signaling and carrying, mitochondrial
biogenesis, as well as certain enzymes implicated in mitochondrial metabolism (Brocherie et al.,
2017b).
Several mechanisms have been proposed to explain the physiological adaptations
mediating athletic performance improvement as a result of RSH (Brocherie et al., 2017a). Galvin
et al. (2013) suggested that performance enhancement associated with RSH was due to decreased
cerebral deoxygenation during training. Gatterer et al. (2015) proposed that the altered redox
status might explain the difference in performance improvement between RSH and RSN. They
reported an identical decrease in markers of oxidative stress at rest with a concomitant increase
in plasma antioxidant activity between RSH and RSN. However, increased redox status,
expressed as a ratio between the oxidative stress and antioxidant potential, was associated with
improvements in RSA mean time. In addition, improvements in YYIR and RSA could be
attributed to the diminished resting oxidative stress. Born et al. (2016) assessed changes in mood
and mucosal immune function before and after six RSH or RSN training sessions conducted over
two weeks, and found increased mucosal immune function with reduced mood for RSH when
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compared with RSN. This is particularly important for athletes competing in winter sports since
reduced mucosal immune function may be associated with higher risk of chronic fatigue,
impaired performance, and overreaching (Papacosta & Nassis, 2011), as well as an elevated
incidence of upper respiratory tract infections (Mortatti et al., 2012).
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Table 1. Summary of studies examined training adaptations to RSH.
Study

Design

Faiss et al.
(2013)
Galvin et al.
(2013)
Gatterer et al.
(2014)
Gatterer et al.
(2015)
Kasai et al.
(2015)
Faiss et al.
(2015)
Brocherie et al.
(2015a)
Brocherie et al.
(2015b)
Goods et al.
(2015)
Brocherie et al.
(2016)
Trincat et al.
(2016)
Montero et al.
(2016)
Hamlin et al.
(2017)

Parallel,
single-blind
Parallel,
single-blind
Parallel,
single-blind
Parallel,
single-blind
Parallel,
single-blind
Parallel,
double-blind
Parallel,
double-blind
Parallel,
double-blind
Parallel,
single-blind
Parallel,
double-blind
Parallel,
unblinded
Crossover,
double-blind
Parallel,
single-blind

Gender, n
(RSH, RSN)
Male
(20, 20)
Male
(15, 15)
Male
(5, 5)
Male
(7, 7)
Female
(16, 16)
Mixed
(9, 8)
Male
(8, 8)
Male
(11, 12)
Male
(9, 10)
Male
(11, 12)
Male
(8, 8)
Male
(15, 15)
Male
(9, 10)

Training Status
Moderately trained
cyclists
Collegiate rugby
players
Youth soccer
players
Amateur soccer
players
Collegiate lacrosse
players
Elite cross-country
skiers
Youth soccer
players
Elite field hockey
players
Trained Australian
footballers
Elite field hockey
players
Highly trained
swimmers
Moderately trained
cyclists
Highly trained
rugby players

O2
Fraction
14.6%
13.0%
14.8%
14.8%
14.5%
13.8%
14.3%
14.2%
Equal to
3000m
14.5%
Equal to
2000m
13.8%
14.5%

Intervention
Duration
8 sessions
over 4 wks.
12 sessions
over 4 wks.
7-8 sessions
over 5 wks.
8 sessions
over 12 days
8 sessions
over 4 wks.
6 sessions
over 2 wks.
10 sessions
over 5 wks.
6 sessions
over 2 wks.
15 sessions
over 5 wks.
6 sessions
over 2 wks.
6 sessions
over 2 wks.
12 sessions
over 4 wks.
6 sessions
over 3 wks.

Training Protocol
sets × reps × time

Recovery time
within/between sets

3 × 5 × 10s, cycling

20s / 5min

1 × 10 × 6s, treadmill
running
3 × 5 × 10s,
overground running
3 × 5 × 10s,
overground running

20s / 5min

2 × 10 × 7s, cycling

30s / 10-20min

4 × 5 × 10s, doublepoling
Varied sets & reps of
15s, treadmill running
4 × 5 × 5s, overground
running
3 × 7 × 5s, cycling
4 × 5 × 5s, overground
running
2 × 16 × 15m, front
crawl swimming

20s / 5min

20s / 5min
15s / 5min
25s / 5min
15-35s / 3min
25s / 5min
30s / 20min

4 × 5 × 10s, cycling

20s / 5min

4 × 5 × 5s, cycling

25s / 5min

Note. n = sample size; RSH = repeated sprint training in hypoxia; RSN = repeated sprint training in normoxia.
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30s / NA

Effects of Beta-alanine Supplementation on Athletic Performance: An Update
Carnosine is an intramuscular dipeptide that is stored within skeletal muscle, which
primarily functions as an intracellular buffer (Suzuki et al., 2006). Additionally, carnosine has
been shown to act as a calcium regulator by increasing calcium sensitivity during contraction
while benefiting calcium release during relaxation (Dutka, Lamboley, McKenna, Murphy, &
Lamb, 2012), and as an antioxidant by scavenging free radicals (Klebanov et al., 1998) and
chelating transition metals (Kohen, Yamamoto, Cundy, & Ames, 1988). As a non-essential, nonproteogenic amino acid, beta-alanine plays a vital role in carnosine synthesis since its availability
is the rate-limiting factor for carnosine synthesis in skeletal muscle (Harris et al., 2006).
Although limited by its low synthesis rate endogenously in the liver, chronic beta-alanine
supplementation has been shown to dramatically increase the intramuscular carnosine content
(Harris et al., 2006). Moreover, there appears to be a dose-response for beta-alanine ingestion
and muscle carnosine synthesis. Changes in muscle carnosine from beta-alanine supplementation
ranged from 20 to 87%, depending upon dose and duration of the use, method of analysis,
muscles examined, and training level of the participants (Hoffman et al., 2015b). Reflecting its
popularity as an ergogenic aid, numerous reviews have been conducted to elaborate the
physiological mechanisms and performance benefits of beta-alanine supplementation across a
wide range of exercise protocols (Bellinger, 2014; Blancquaert, Everaert, & Derave, 2015;
Derave et al., 2010; Hobson et al., 2012; Hoffman et al., 2014; Hoffman et al., 2015a; Hoffman
et al., 2015b; Quesnele, Laframboise, Wong, Kim, & Wells, 2014; Sale et al., 2010; Trexler et
al., 2015).
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Relationship between beta-alanine supplementation and repeated sprint performance
It is a widely held view that 1.6 - 6.4 g·day-1 of beta-alanine supplementation over 4 - 6
weeks can improve exercise performance, especially for open end-point tasks and time trials
lasting one to four minutes in duration (Hoffman, Emerson, & Stout, 2012; Trexler et al., 2015).
In a recent meta-analysis, Saunders et al. (2016) concluded that high intensity exercise between
30 seconds and 10 minutes resulted in the greatest performance gains from beta-alanine
supplementation, while those lasting less than 30 seconds did not appear to benefit from
supplementation. Repeated efforts of high intensity exercise invoke muscle acidosis (Bishop,
Edge, Davis, & Goodman, 2004) due to the considerable reliance on glycolytic ATP resynthesis
(Belfry et al., 2012). Increases in muscle carnosine content resulting from beta-alanine
supplementation has been shown to enhance muscle buffering capacity (Abe, 2000), potentially
improving repeated sprint performance. However, little attention has been paid to the benefits of
beta-alanine supplementation on repeated-effort, short-duration exercises. Therefore, the purpose
of the following sections is to review the most recent publications (see Table 2) and provide an
update on the effects of beta-alanine supplementation on athletic performance with a focus on
repeated sprint ability.
Effects of beta-alanine supplementation without prescribed training on repeated sprint
performance
Derave et al. (2007) reported that elevated muscle carnosine levels attenuated fatigue
during the later stages of repeated, exhaustive bouts of isokinetic knee extensions. However, it
should be noted that isokinetic movement can only be accomplished using a dynamometer,
therefore, this testing modality has limited practical implications. Sweeney, Wright, Glenn Brice,
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and Doberstein (2010) extended the testing protocol to treadmill running sprints and found no
ergogenic effect of beta-alanine supplementation on repeated sprint performance. The authors
speculated that their repeated sprint protocol may have required a greater reliance on PCr
resynthesis rather than the removal of H+. Although the average lactate concentration after
testing was about 12 mmol·L-1, it should be noted that the blood sample was collected five
minutes after exercise. Therefore, it is difficult to exclude the possibility that the exercise
intensity utilized during testing was insufficient to challenge muscle buffering capacity. Saunders
et al. (2014) also employed treadmill running and examined the effects of beta-alanine
supplementation on repeated sprint performance in hypoxia, which should increase the reliance
on anaerobic glycolysis and muscle buffering capacity. However, repeated sprint performance
was not improved following beta-alanine supplementation. This was consistent with their
previous study (Saunders, Sale, Harris, & Sunderland, 2012), which showed no effect of betaalanine on repeated 15m sprints during the Loughborough intermittent shuttle test. Again, the
reported low lactate levels (3-6 mmol·L-1) after testing indicated that the intensity of the test
employed may not have been sufficient to challenge muscle buffering capacity and elicit
performance decrements. Similarly, Ducker, Dawson, and Wallman (2013) found that betaalanine only marginally improved performance during repeated sprints. Noteworthy, the testing
protocol (Ducker et al., 2013) only resulted in limited elevation of blood lactate concentrations
(7-8 mmol·L-1) and decrease in blood pH (about 7.3). Hoffman et al. (2015a) reported no effect
of beta-alanine ingestion on repeated sprint performance in soldiers. The authors suggested that
the short duration (less than 10s) and low number (e.g., five) of sprints was unlikely to induce a
significant decline in muscle pH.

18

Recently, two studies reported ergogenic benefits of beta-alanine supplementation on
repeated front crawl swimming sprints in water polo athletes (Brisola, Artioli, Papoti, & Zagatto,
2016; Claus et al., 2017). More specifically, Brisola et al. (2016) found a likely beneficial effect
on repeated sprint performance in trained athletes, whereas Claus et al. (2017) reported a
significant improvement in mean time and total time during repeated front crawl swimming
sprints, as well as an increased throwing velocity and fatigue resistance in a specific water polo
repeated sprint testing. This is consistent with Tobias et al. (2013), who demonstrated that betaalanine supplementation significantly increased total work during a repeated upper-body
Wingate test. In addition, the investigators also noted increased peak and mean power during
testing accompanied with an augmented blood lactate response (increased from 11 to 13
mmol·L-1) immediately after testing. Likewise, de Andrade Kratz et al. (2016) demonstrated that
beta-alanine supplementation successfully improved performance in a repeated judo specific
fitness test, and elicited greater blood lactate concentrations (increased from 9 to 12 mmol·L-1)
immediately after testing.
Effects of beta-alanine supplementation combined with prescribed training on repeated
sprint performance
All of the aforementioned studies involved participants maintaining their regular training
or physical activity as opposed to incorporating training interventions with beta-alanine
supplementation. Only two studies have provided prescribed short-duration training involving
repeated efforts with evaluation of changes in repeated sprint performance. Cochran et al. (2015)
reported that beta-alanine supplementation prior to and during six weeks of sprint interval
training increased muscle carnosine level by about 50% in active men, but did not enhance
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training workload or repeated Wingate performance. Blood lactate levels were not reported. The
authors explained that the ergogenic benefits of beta-alanine may have been masked by the
increased skeletal muscle buffering capacity elicited by the sprint interval training program. In
contrast, Bellinger and Minahan (2016a) reported that beta-alanine supplementation enhanced
sprint interval training intensity and resulted in additional benefits to repeated sprint performance
in trained cyclists than sprint interval training only. The investigators also reported that blood
lactate concentrations in the beta-alanine group were significantly higher than in the placebo
group following the last two bouts of 4 × 1 km sprint cycling sessions. The inconsistency in
these findings may be attributed to differences in training status of the participants, training
interventions, and testing protocols. Therefore, future studies should address the underlying
mechanisms of these discrepancies.
Co-ingestion of beta-alanine and other supplements on repeated sprint performance
Muscle buffering capacity refers to the ability to buffer or regulate proton accumulation
resulting from muscle acidosis (Edg, Bishop, Hill-Haas, Dawson, & Goodman, 2006). Acid
buffers within the human body are generally categorized into intracellular and extracellular
buffers. In theory, repeated sprint performance could be enhanced if any of these buffering
systems are enhanced. The additive effects of beta-alanine and sodium bicarbonate co-ingestion
on repeated sprint performance has been previously examined, with conflicting results. Saunders
et al. (2014) reported no additive effects of co-supplementation on repeated treadmill running
sprints, while Ducker et al. (2013) suggested that an acute dose of sodium bicarbonate ingestion
improved repeated sprint performance more than beta-alanine supplementation alone and coingestion. Interestingly, Tobias et al. (2013) demonstrated that chronic beta-alanine and sodium
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bicarbonate supplementation separately improved repeated upper-body Wingate performance to
a similar extent, whereas co-ingestion elicited an additive ergogenic effect.
Conclusion
Both RSH and beta-alanine supplementation have been shown to benefit performance.
Previous research indicates that these interventions have different mechanisms of action.
Consequently, a potential additive effect may exist if RSH and beta-alanine supplementation are
combined. To the best of our knowledge, no study has examined the additive effect of RSH and
beta-alanine supplementation. Therefore, the aim of this investigation was evaluate whether RSH
plus beta-alanine supplementation elicited greater performance and physiological adaptations
when compared to individual interventions involving only RSH or beta-alanine supplementation.
The expected outcome of these comparisons was that both groups would improve performance
after intervention, and that greater muscle buffering capacity in the combined group would result
in greater improvements in working capacity, exercise tolerance, and recovery in comparison to
RSH or beta-alanine supplementation alone.
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Table 2. Summary of studies examined ergogenic effects of beta-alanine on repeated sprint performance.
Study

Parallel design

Derave et al.
(2007)
Sweeney et al.
(2010)
Saunders et al.
(2012)
Saunders et al.
(2012)
Ducker et al.
(2013)
Tobias et al.
(2013)
Saunders et al.
(2014)
Cochran et al.
(2015)
Hoffman et al.
(2015)
Bellinger et al.
(2016)
Brisola et al.
(2016)
de Andrade Kratz
et al. (2016)
Claus et al.
(2017)

Double-blind,
placebo-controlled
Double-blind, nonplacebo controlled
Double-blind,
placebo-controlled
Double-blind,
placebo-controlled
Single-blind,
placebo-controlled
Double-blind,
placebo-controlled
Double-blind,
placebo-controlled
Double-blind,
placebo-controlled
Double-blind,
placebo-controlled
Double-blind,
placebo-controlled
Double-blind,
placebo-controlled
Double-blind,
placebo-controlled
Double-blind,
placebo-controlled

Gender
(BA, PL)
Male
(8, 7)
Male
(9, 10)
Male
(8, 8)
Male
(10, 10)
Male
(6, 6)
Male
(10, 9)
Male
(8, 8)
Male
(12, 12)
Male
(9, 9)
Male
(7, 7)
Male
(11, 11)
Male
(12, 11)
Male
(7, 7)

Training status
Trained track &
field athletes
Active
individuals
Elite hockey
players
Active
individuals
Competitive
athletes
Trained judo &
jiu-jitsu athletes
Active
individuals
Active
individuals

Total
dosage
134.4g
154.0g
179.2g
179.2g
168.0g
179.2g
201.6g
224.0g

Elite Soldiers

180.0g

Trained cyclists

179.2g

Trained water
polo athletes
Trained judo
athletes
Youth water
polo athletes

163.2g
179.2g
268.8g

Training
protocol
Non-prescribed
training
Non-prescribed
training
Non-prescribed
training
Non-prescribed
training
Non-prescribed
training
Non-prescribed
training
Non-prescribed
training
Prescribed sprint
interval training
Non-prescribed
training
Prescribed sprint
interval training
Non-prescribed
training
Non-prescribed
training
Non-prescribed
training

Performance testing
5 × 30 isokinetic knee extensions at
180°/s with 1min rest
2 × 5 × 5s treadmill running with
45s/2min rest intra/inter sets
Loughborough intermittent shuttle test
Loughborough intermittent shuttle test
3 × 6 × 20m overground running with
25s/4min rest intra/inter sets
4 × 30s upper-body Wingate test with
3min rest
5 × 6s treadmill running with 24s rest
4 × 30s Wingate test with 4min rest
5 × 30m sprints with 5s shooting
4 × 1km cycling sprints with 4min rest
6 × 10m front crawl swimming sprints
with 17s rest
3 bouts of judo specific fitness test with
3min rest
8 × 15m front crawl swimming sprints
with 30s rest

Note. n = sample size; RSH = repeated sprint training in hypoxia; RSN = repeated sprint training in normoxia.
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CHAPTER THREE: METHODOLOGY
Participants
Fifty-two healthy men were recruited by word of mouth and flyers. Participants with
exposure to altitude over 1,500m during the previous 6 months were excluded. Among the 52
eligible participants initially recruited, two individuals withdrew from the study due to training
intolerance, 12 individuals did not finish the training protocol due to reasons not directly related
to the study. Consequently, 38 participants (see Table 3) completed all testing, training and
supplementation protocols and their data were included in the final analysis. Participants were
recreationally active. Participants were non-smokers and did not use any supplements that
contained beta-alanine for at least 9 weeks prior to the study, or during the study period. They
were instructed to maintain their habitual physical activity level (5-7 hours resistance/endurance
training per week) and normal diet throughout the study. This investigation was approved by the
University of Central Florida Institutional Review Board. All participants provided written
informed consent after clearing any physical and medical limitations, as determined by Medical
and Activity History Questionnaire and Physical Activity Readiness Questionnaire, and being
fully informed about the content of the study and the risks involved.
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Table 3. Participant characteristics.
HB (n = 10)

HP (n = 9)

NB (n = 11)

NP (n = 8)

Age (y)

22.5 ± 2.7

22.7 ± 2.8

22.6 ± 2.9

22.6 ± 2.9

Height (cm)

174.9 ± 6.9

174.8 ± 7.2

175.2 ± 6.8

174.5 ± 7.4

Body Mass (kg)

76.9 ± 8.4

76.3 ± 9.2

76.7 ± 8.9

76.5 ± 9.3

Note. Data are mean ± standard deviation (SD) and represent baseline characteristics of the participants
training in hypoxia while receiving beta-alanine (HB) or placebo (HP) supplementation and participants
training in normoxia while receiving beta-alanine (NB) or placebo (NP) supplementation. n = sample
size.

Experimental Design
This investigation employed a randomized, double-blind, placebo controlled design, and a
single-blind manner for training. All participants completed a resting blood draw, body
composition assessments, and graded exercise testing on day 1, a lower body repeated sprint
testing on day 2, and a 3-min all-out cycling testing on day 3. Following the pre-testing (PRE)
assessment, participants were evenly divided into 4 groups: normoxia + placebo group (NP),
hypoxia + placebo group (HP), normoxia + beta-alanine group (NB) and hypoxia + beta-alanine
group (HB). The fraction of inspired oxygen and simulated altitude were 14.5-14.2% (e.g., 28003000 m) for hypoxia, and 20.9-20.1% and (e.g. 0-300 m) for normoxia, respectively. To compare
changes in anaerobic performance, each group completed a 4-week training program (two
sessions per week) and supplementation protocol (6.4 g per day) under the direct supervision of
certified strength and conditioning specialists (CSCS). Participants completed at least 95% of
their respective repeated sprints and 95% of the supplementation protocol over the course of 4week period. Post-testing (POST) occurred following the completion of the 4-week training
program. The study design is illustrated in Figure 1.
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Screen Visit

• Informed Consent
• Medical and Activity History Questionnaire
• Physical Activity Readiness Questionnaire

Pre-Testing

•
•
•
•

Intervention

• 4-week training & supplementation
• Repeated Sprint Training in Hypoxia / Normoxia
• Beta-alanine / Placebo

Post-Testing

•
•
•
•

Anthropometric & Blood Measures (Day 1)
Graded Exercise Testing (Day 1)
Repeated Sprint Testing (Day 2)
3-Min All-Out Testing (Day 3)

Anthropometric & Blood Measures (Day 1)
Graded Exercise Testing (Day 1)
Repeated Sprint Testing (Day 2)
3-Min All-Out Testing (Day 3)

Figure 1. Illustration of study design.
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Anthropometric assessments
Anthropometric measurements for all participants were conducted in the following
sequence: height, body mass and body composition. Height (± 0.1 cm) and body mass (± 0.1 kg)
were determined using a Health-o-meter Professional (Patient Weighing Scale, Model 500 KL,
Pelstar, Alsip, IL, USA) with the participants standing barefoot, with feet together, in their
normal daily attire. Body composition were determined using air displacement plethysmography.
Participants dressed down to their undergarments, removed their footwear, including socks, put
on a swim cap provided and sit in the device (BOD POD, COSMED, Rome, Italy) for
measurement to determine body composition. Values for body fat percentage were recorded.
Graded exercise testing
An incremental test to volitional exhaustion was performed by each participant on a cycle
ergometer to determine maximal oxygen consumption (VO2peak), gas exchange threshold
(GET), and respiratory compensation point (RCP). Prior to testing, each participant completed a
standardized warm-up consisting of 5-min cycling at 120W and a dynamic stretch which
included 10 repetitions of body weight squats, alternating lunges, walking knee hugs and
walking butt kicks. Following the warm-up, each participant was fitted with a heart rate monitor
to record the participants’ heart rate. Participants maintained a pedaling cadence of 70–75
revolutions per minute (RPM) at an initial workload of 60 W. The workload increased 1 W every
3 s until the participant was unable to maintain a cadence above 70 RPM for 10 s despite verbal
encouragement, or volitional fatigue. Prior to each graded exercise test, metabolic gas analyzer
(Quark CPET, COSMED, Rome, Italy) was calibrated with room air and gases of known
concentration. Oxygen (O2), carbon dioxide (CO2), ventilation (VE), and respiratory exchange
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ratio (RER) will be monitored continuously and expressed breath-by-breath. VO2peak was
determined as the highest VO2 value. The GET was defined as the VO2 value corresponding to
the intersection of two linear regression lines derived separately from the data points below and
above the breakpoint in the carbon dioxide production rate (VCO2 -versus- VO2 relationship).
The RCP was defined as the VO2 value corresponding to the point of departure from linearity of
the VE -versus- VCO2 relationship.
Repeated sprint testing
Each participant performed a total of six 10-second lower-body cycling Wingate tests with a
7.5% body mass loading which was interspersed with 60 s active recovery periods. Besides the
standardized warm-up described previously, the participants also completed several short sprints
on the ergometer (894E, Monark Exercise AB, Vansbro, Sweden) at the same resistance to be
used during the test. Following the warm-up and prior to each successive sprint, the participants
commenced with maximal pedaling after a standardized 10 s countdown. Verbal encouragement
was provided throughout the sprints. At the end of the test, the load was removed and the
participant continued to exercise at 60 RPM on the unloaded ergometer for at least 5 min. Peak
power, mean power and fatigue index was recorded. Using a metabolic gas analyzer (Quark
CPET, COSMED, Rome, Italy), metabolic data during the testing was also collected for later
analysis.
3-min all-out testing
Each participant performed the 3-min maximal effort cycling test using a calibrated
electronically braked cycle ergometer (Excalibur, Lode, Groningen, the Netherlands). Following
the aforementioned standardized warm-up, the participant completed 60 s of unloaded cycling at
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90 RPM, followed by an all-out 3-min effort with resistance being set as a function of pedaling
rate. Participants was asked to accelerate to approximately 110 RPM over the last 5 s of the
baseline period. The resistance was adjusted during the all-out effort using the pedaling rate
dependent linear mode on the cycle ergometer that used a linear factor (power/cadence2) based
on the power output at a given pedaling rate (70 RPM) being equal to 50% of the difference
between the power output at GET and VO2peak assessed during the graded exercise test
described previously (Wang et al., 2017). To prevent pacing and ensure an all-out effort, the
participant was not aware of the elapsed time and strong verbal encouragement was provided.
Critical power was calculated as the average power output during the final 30 s of the test and
anaerobic working capacity was calculated as the work-time integral above critical power.
Additionally, metabolic data during the testing was also collected via a metabolic gas analyzer
(Quark CPET, COSMED, Rome, Italy).
Repeated sprint training intervention
A repeated sprint training program (see Figure 2) consisting of eight training sessions (2
sessions per week for 4 weeks) was employed and each session was separated by at least 48 h.
The HP and HB groups trained under hypoxia, while the NP and NB groups trained under
normoxia. Following a standardized warm-up, the participants completed three sets of 5 × 10 s
all-out repeated sprints with a 7.5% body mass loading which was interspersed with 20 s active
recovery periods. A 5-min recovery period at was given between sets and each training protocol
ended with a 10-min recovery period. Subjects was instructed to perform all-out sprints trying to
reach and maintain the highest power output for every sprint, and strong verbal encouragement
was given during each sprint. Heart rate from a wireless device (BioHarness 3, Zephyr
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Technology Corporation, Annapolis, MD) and arterial oxygen saturation (SpO2) via pulse
oximeter (GO2, Nonin Medical, Inc., Plymouth, MN) was monitored throughout each training
session. SpO2 decline was calculated as the average value of the delta changes between the SpO2
value at the beginning and the end of each training session.

Figure 2. Illustration of a repeated training session.
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Beta-alanine supplementation
The NB and HB groups received 6.4 g of sustained release beta-alanine (Natural
Alternative Inc, Carlsbad, CA) per day during the 4-week period, while the HP and NP groups
received the same amount of placebo (rice powder) throughout the study. The dosing regimen
was similar to that reported by Saunders et al. (2014) consisting of two 800 mg beta-alanine or
placebo tablets ingested four times per day at 3-4 hour intervals for 28 days. Compliance was
monitored using supplementation logs. Additionally, participants completed a 3-day dietary
recall before and after the supplementation period.
Blood samples
Blood samples was collected during the testing sessions before and after the 4-week
training period. During day 1, a resting blood sample was obtained by venipuncture of the
forearm vein following a 15-min equilibration period. All blood samples were collected into a
Vacutainer® tubes containing K3EDTA (4 ml) for determination of hematocrit and hemoglobin
concentrations. In addition, blood samples were also obtained by finger-prick before and after
the repeated sprint test and the critical power test to determine blood lactate concentration.
Biochemical analysis
The hemoglobin and hematocrit was measured immediately after the blood draw via a
hematology analyzer (Ac·T diff2™, Beckman Coulter, Brea, CA), which was calibrated every
day using control reagents. Coefficients of variation for each assay was 6.3 % for hemoglobin,
and 6.1 % for hematocrit. Blood lactate concentrations were analyzed using a portable device
(Lactate Plus, Nova Biomedical, Waltham MA) from 20- µl fingertip capillary blood.
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Statistical analysis
One-way (Group) analysis of variance (ANOVA) was performed to compare training
volume, supplementation compliance, and SpO2 during training. Since there were no baseline
differences, one-way (Group) ANOVA with repeated measures (pre-test vs post-test) was
performed to examine pre-post changes for anthropometric and hematological measures. To
account for baseline differences between groups, two-way (Altitude x Supplement) analysis of
covariance (ANCOVA) was performed on post-test values for all performance measures between
groups with pre-test values serving as the covariate. The assumptions of normality, linearity,
homogeneity of variances, homogeneity of regression slopes, and reliable measurement of the
covariate were verified. For effect size, the partial eta squared statistic was calculated, and 0.01,
0.06, and 0.14 was interpreted as small, medium, and large effect sizes, respectively. An alpha of
p < 0.05 was established a priori. All data were reported as mean ± SD. In addition, post-test
performance measures were reported as mean ± 95% confidence intervals to indicate meaningful
changes as compared with covariate adjusted pre-test values. Statistical software (IBM SPSS
Statistics for Windows, Version 22.0; Armonk, NY: IBM Corp) was used for all analyses.
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CHAPTER FOUR: RESULTS
Training Volume and Supplementation Compliance
No significant difference was observed between groups for training volume (F3, 33 =
1.268, p = 0.301) or supplementation compliance (F3, 33 = 1.541, p = 0.222). NB, NP, HB, and
HP consumed 179.2 ± 0.0 g, 175.7 ± 4.3 g, 178.6 ± 1.1 g, and 177.2 ± 4.2 g out of 180 g of the
provided supplement and completed, 120.0 ± 0.0, 115.9 ± 10.5, 119.1 ± 1.7, and 119.8 ± 0.7 of
the 120 required sprints, respectively.
Arterial Oxygen Saturation during Training
Significant differences were noted in SpO2 measures at rest (F3, 33 = 185.299, p = 0.01);
during training (F3, 33 = 64.695, p = 0.01) and the difference (∆) from training and rest (F3, 33 =
19.763, p = 0.01). Resting SpO2 values for NB (96.4 ± 0.9 %) and NP (97.2 ± 0.7 %) were
significantly higher (p = 0.01) than that observed for HB (88.8 ± 1.1 %) and HP (89.6 ± 1.1 %).
Training SpO2 values for NB (94.1 ± 3.5 %) and NP (95.7 ± 0.8 %) were significantly greater (p
= 0.01) than that for HB (78.6 ± 2.7 %) and HP (81.5 ± 4.6 %). SpO2 decline for NB (2.3 ±
3.5 %) and NP (1.5 ± 0.9 %) were significantly lower (p = 0.01) than that for HB (10.2 ± 2.4 %)
and HP (8.0 ± 3.8 %). No difference (p > 0.05) were noted between NB and NP, or between HB
and HP.
Anthropometric and Hematological Measures
No significant interaction was observed between time and group (F3, 33 = 0.632, p =
0.600, η2 = 0.054) for body mass, nor was any significant main effect for time noted (F3, 33 =
0.654, p = 0.424, η2 = 0.019). No significant interaction was observed between time and group
(F3, 33 = 1.158, p = 0.341, η2 = 0.095) for percent body fat, nor was there a main effect for time
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noted (F3, 33 = 0.717, p = 0.403, η2 = 0.021). No significant interaction was observed between
time and group (F3, 33 = 0.291, p = 0.832, η2 = 0.026) for hemoglobin, and no main effect for
time was noted (F3, 33 = 1.026, p = 0.319, η2 = 0.030). No significant interaction was observed
between time and group (F3, 33 = 0.093, p = 0.963, η2 = 0.008) for hematocrit, and no main effect
for time was noted (F3, 33 = 2.507, p = 0.123, η2 = 0.071). Results indicated that anthropometric
and hematological measures were unchanged before and following intervention for all groups
(see Table 4).
Graded Exercise Testing
Unadjusted raw data for graded exercise testing variables are shown in Table 5.
ANCOVA results with covariate values are shown in Figure 3.
Maximal oxygen consumption (VO2max)
No significant altitude x supplement interaction was noted (F1, 32 = 0.864, p = 0.360, η2 =
0.026). In addition, no main effects for altitude (F1, 32 = 3.842, p = 0.059, η2 = 0.107) or
supplement (F1, 32 = 0.050, p = 0.824, η2 = 0.002) were observed.
Peak power output (PPO)
No significant altitude x supplement interaction was noted (F1, 32 = 0.305, p = 0.584, η2 =
0.009). In addition, no main effects for altitude (F1, 32 = 0.417, p = 0.523, η2 = 0.013) or
supplement (F1, 32 = 0.275, p = 0.604, η2 = 0.009) were observed.
Oxygen consumption at RCP (VO2RCP)
No significant altitude x supplement interaction was noted (F1, 32 = 0.020, p = 0.888, η2 =
0.001). In addition, no main effect for supplement (F1, 32 = 0.014, p = 0.908, η2 = 0.001) was
noted as well. However, a main effect for altitude (F1, 32 = 5.029, p = 0.032, η2 = 0.136) was
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observed, with the collapsed values for HB and HP (38.44 ± 3.33 ml·min·kg-1) being greater than
that of NB and NP (35.96 ± 3.36 ml·min·kg-1).
Power output at RCP (PRCP)
No significant altitude x supplement interaction was noted (F1, 32 = 1.754, p = 0.195, η2 =
0.052). In addition, no main effect for supplement (F1, 32 = 0.044, p = 0.834, η2 = 0.001) was
noted as well. However, a main effect for altitude (F1, 32 = 5.091, p = 0.031, η2 = 0.137) was
observed, with the collapsed values for HB and HP (2.91 ± 0.18 W·kg-1) being greater than that
of NB and NP (2.77 ± 0.19 W·kg-1).
Repeated sprint testing
Unadjusted raw data for repeated sprint testing variables are shown in Table 6. ANCOVA
results with covariate values are shown in Figure 4.
Average power output of all sprints (RST_AP)
No significant altitude x supplement interaction was noted (F1, 32 = 1.252, p = 0.272, η2 =
0.038). In addition, no main effects for altitude (F1, 32 = 2.158, p = 0.152, η2 = 0.063) or
supplement (F1, 32 = 0.864, p = 0.360, η2 = 0.026) were noted as well.
Average power output of the last sprint (RST_AP5)
No significant altitude x supplement interaction was noted (F1, 32 = 0.091, p = 0.765, η2 =
0.003). In addition, no main effect for supplement (F1, 32 = 0.008, p = 0.930, η2 = 0.001) was
noted. However, a main effect for altitude (F1, 32 = 4.107, p = 0.050, η2 = 0.114) was noted, with
the collapsed values for HB and HP (8.66 ± 0.51 W·kg-1) being greater than that of NB and NP
(8.32 ± 0.51 W·kg-1).
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Lactate concentration after RST (RST_La)
No significant altitude x supplement interaction was observed (F1, 32 = 0.053, p = 0.819,
η2 = 0.002). In addition, no main effects for altitude (F1, 32 = 0.284, p = 0.598, η2 = 0.009) or
supplement (F1, 32 = 2.664, p = 0.112, η2 = 0.077) were noted.
Heart rate at 60s after RST (RST_HR60)
No significant altitude x supplement interaction was noted (F1, 30 = 1.802, p = 0.190, η2 =
0.057). In addition, no main effect for supplement (F1, 30 = 1.154, p = 0.291, η2 = 0.037) was
observed. However, a main effect for altitude (F1, 30 = 5.370, p = 0.027, η2 = 0.152) was noted,
with the collapsed values for HB and HP (144.79 ± 7.52 bpm) being smaller than that of NB and
NP (150.29 ± 7.62 bpm).
3-Min All-Out Testing
Unadjusted raw data for 3-min all-out testing variables are shown in Table 7. ANCOVA
results with covariate values are shown in Figure 5.
Critical power (CP)
No significant altitude x supplement interaction was noted (F1, 32 = 0.124, p = 0.727, η2 =
0.004). In addition, no main effects for altitude (F1, 32 = 4.103, p = 0.051, η2 = 0.114) or
supplement (F1, 32 = 0.691, p = 0.412, η2 = 0.021) were observed.
Anaerobic working capacity (AWC)
No significant altitude x supplement interaction was observed (F1, 32 = 1.561, p = 0.221,
η2 = 0.047). In addition, no main effect for altitude (F1, 32 = 2.627, p = 0.115, η2 = 0.076) was
noted. However, a main effect for supplement (F1, 32 = 5.570, p = 0.025, η2 = 0.148) was noted,
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with the collapsed values for HB and NB (0.24 ± 0.04 kJ·kg-1) being greater than that of HP and
NP (0.21 ± 0.03 kJ·kg-1).
Total work (TW)
No significant altitude x supplement interaction was noted (F1, 32 = 1.640, p = 0.209, η2 =
0.049). In addition, no main effect for supplement (F1, 32 = 1.866, p = 0.182, η2 = 0.055) was
observed. A main effect for altitude (F1, 32 = 9.402, p = 0.004, η2 = 0.227) was noted, with the
collapsed values for HB and HP (0.73 ± 0.03 kJ·kg-1) being greater than that of NB and NP (0.70
± 0.03 kJ·kg-1).
Lactate concentration after CP (CP_La)
No significant altitude x supplement interaction was observed (F1, 32 = 0.109, p = 0.744, η2 =
0.003). In addition, no main effects for altitude (F1, 32 = 0.022, p = 0.883, η2 = 0.001) or
supplement (F1, 32 = 1.024, p = 0.319, η2 = 0.031) were noted as well.
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Note. Mean values (±95% confidence interval) for posttest adjusted for initial differences in pretest (dash
line) for normoxia + beta-alanine group (NB), normoxia + placebo group (NP), hypoxia + beta-alanine
group (HB) and hypoxia + placebo group (HP): A. Average power output of all sprints (RST_AP;
covariate: adjusted pretest mean = 8.68 W·kg-1); B. Average power output of the last sprint (RST_AP5;
covariate: adjusted pretest mean = 7.03 W·kg-1); C. Lactate concentration after repeated sprint testing
(RST_La; covariate: adjusted pretest mean = 12.61 mmol·L-1); D. Hear rate at 60s after repeated sprint
testing (RST_HR60; covariate: adjusted pretest mean = 147.94 bpm); # indicates main effect for altitude.

Figure 3. Graded exercise testing variables after 4 weeks of training.
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Note. Mean values (±95% confidence interval) for posttest adjusted for initial differences in pretest (dash
line) for normoxia + beta-alanine group (NB), normoxia + placebo group (NP), hypoxia + beta-alanine
group (HB) and hypoxia + placebo group (HP): A. Average power output of all sprints (RST_AP;
covariate: adjusted pretest mean = 8.68 W·kg-1); B. Average power output of the last sprint (RST_AP5;
covariate: adjusted pretest mean = 7.03 W·kg-1); C. Lactate concentration after repeated sprint testing
(RST_La; covariate: adjusted pretest mean = 12.61 mmol·L-1); D. Hear rate at 60s after repeated sprint
testing (RST_HR60; covariate: adjusted pretest mean = 147.94 bpm); # indicates main effect for altitude.

Figure 4. Repeated sprint testing variables after 4 weeks of training.
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Note. Mean values (±95% confidence interval) for posttest adjusted for initial differences in pretest (dash
line) for normoxia + beta-alanine group (NB), normoxia + placebo group (NP), hypoxia + beta-alanine
group (HB) and hypoxia + placebo group (HP): A. Critical power (CP; covariate: adjusted pretest mean =
2.40 W·kg-1); B. Anaerobic working capacity (AWC; covariate: adjusted pretest mean = 0.24 kJ·kg-1); C.
Total work (TW; covariate: adjusted pretest mean = 0.67 kJ·kg-1); D. Lactate concentration after 3-min
all-out testing (CP_La; covariate: adjusted pretest mean = 14.33 mmol·L-1); # indicates main effect for
altitude; * indicates main effect for supplement.

Figure 5. 3-min all-out testing variables after 4 weeks of training.

39

Table 4. Anthropometric and hematological variables before (pre-) and after (post-) intervention.
NB (n = 11)

NP (n = 8)

HB (n = 10)

HP (n = 9)

Pre-

Post-

Pre-

Post-

Pre-

Post-

Pre-

Post-

BM (kg)

78.2 ± 11.6

77.8 ± 10.2

81.4 ± 7.9

81.7 ± 7.8

72.4 ± 4.3

73.3 ± 4.8

72.3 ± 8.4

72.5 ± 7.5

%BF

20.1 ± 8.1

19.2 ± 8.4

18.8 ± 8.4

18.7 ± 9.3

14.5 ± 4.5

14.8 ± 4.3

15.6 ± 4.8

15.3 ± 5.1

Hb (g·dl-1)

15.1 ± 0.8

14.9 ± 0.8

14.2 ± 0.9

14.1 ± 1.0

14.5 ± 0.8

14.5 ± 0.9

14.7 ± 1.1

14.5 ± 1.1

Hct (%)

42.8 ± 3.0

44.0 ± 2.5

41.2 ± 2.7

42.2 ± 2.5

41.5 ± 2.2

42.5 ± 2.3

42.2 ± 2.7

42.7 ± 2.6

Note. Data are mean ± standard deviation (SD) and represent raw data measured before and following
intervention for the participants training in normoxia while receiving beta-alanine (NB) or placebo (NP)
supplementation and participants training in hypoxia while receiving beta-alanine (HB) or placebo (HP)
supplementation. n = sample size. BM = body mass; %BF = percent body fat; Hb = hemoglobin; Hct =
hematocrit.

Table 5. Graded exercise testing variables before (pre-) and after (post-) intervention.
NB (n = 11)

NP (n = 8)

HB (n = 10)

HP (n = 9)

Pre-

Post-

Pre-

Post-

Pre-

Post-

Pre-

Post-

VO2max
(ml·min-1·kg-1)

41.7 ± 4.8

42.8 ± 4.8

38.0 ± 7.3

40.4 ± 6.3

45.1 ± 6.0

47.8 ± 5.2

41.6 ± 3.1

44.1 ± 2.6

PPO (W)

257 ± 45

272 ± 39

247 ± 32

264 ± 28

262 ± 44

279 ± 43

244 ± 21

260 ± 21

VO2RCP
(ml·min-1·kg-1)

37.0 ± 3.9

36.4 ± 5.3

33.6 ± 6.6

34.3 ± 4.7

38.3 ± 6.3

39.8 ± 4.4

35.8 ± 4.4

38.0 ± 4.0

PRCP (W)

211 ± 37

217 ± 35

205 ± 30

210 ± 21

213 ± 38

222 ± 34

195 ± 18

211 ± 21

Note. Data are mean ± standard deviation (SD) and represent raw data measured before and following
intervention for the participants training in normoxia while receiving beta-alanine (NB) or placebo (NP)
supplementation and participants training in hypoxia while receiving beta-alanine (HB) or placebo (HP)
supplementation. n = sample size. VO2max = maximal oxygen consumption; PPO = peak power output;
VO2RCP = oxygen consumption at respiratory compensation point; PRCP = power output at respiratory
compensation point.
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Table 6. Repeated sprint testing variables before (pre-) and after (post-) intervention.
NB (n = 11)

NP (n = 8)

HB (n = 10)

HP (n = 9)

Pre-

Post-

Pre-

Post-

Pre-

Post-

Pre-

Post-

RST_AP (W)

649 ± 115

728 ± 123

700 ± 105

780 ± 119

650 ± 94

726 ± 87

642 ± 114

733 ± 110

RST_AP5 (W)

523 ± 121

629 ± 125

559 ± 103

674 ± 99

538 ± 114

656 ± 87

517 ± 106

631 ± 91

13.2 ± 3.1

12.0 ± 3.3

12.2 ± 3.2

12.9 ± 2.6

13.0 ± 1.9

11.3 ± 1.8

12.0 ± 3.3

12.6 ± 2.6

147 ± 20

150 ± 19

148 ± 5

150 ± 12

145 ± 18

139 ± 17

150 ± 14

151 ± 10

RST_La
(mmol·L-1)
RST_HR60
(bpm)

Note. Data are mean ± standard deviation (SD) and represent raw data measured before and following
intervention for the participants training in normoxia while receiving beta-alanine (NB) or placebo (NP)
supplementation and participants training in hypoxia while receiving beta-alanine (HB) or placebo (HP)
supplementation. n = sample size. RST_AP = average power output of all sprints in repeated sprint
testing; RST_AP5 = average power output of the last sprint in repeated sprint testing; RST_La = lactate
concentration after repeated sprint testing; RST_HR60 = heart rate at 60s after repeated sprint testing.

Table 7. 3-min all-out testing variables before (pre-) and after (post-) intervention.
NB (n = 11)

NP (n = 8)

HB (n = 10)

HP (n = 9)

Pre-

Post-

Pre-

Post-

Pre-

Post-

Pre-

Post-

CP (W)

189 ± 51

203 ± 33

177 ± 46

210 ± 30

186 ± 38

212 ± 35

171 ± 22

202 ± 17

AWC (kJ)

16.8 ± 3.6

17.9 ± 4.4

19.2 ± 6.3

16.0 ± 4.1

18.0 ± 3.9

18.0 ± 3.1

18.3 ± 3.7

17.2 ± 3.7

TW (kJ)

50.8 ± 10.3

54.5 ± 9.5

51.1 ± 7.9

53.7 ± 7.5

51.4 ± 7.5

56.2 ± 8.0

49.0 ± 5.3

53.5 ± 4.7

CP_La
(mmol·L-1)

15.6 ± 2.5

15.0 ± 3.2

12.6 ± 2.7

14.5 ± 2.2

15.5 ± 2.9

14.5 ± 3.3

13.1 ± 3.7

14.8 ± 2.7

Note. Data are mean ± standard deviation (SD) and represent raw data measured before and following
intervention for the participants training in normoxia while receiving beta-alanine (NB) or placebo (NP)
supplementation and participants training in hypoxia while receiving beta-alanine (HB) or placebo (HP)
supplementation. n = sample size. CP = critical power; AWC = anaerobic working capacity; TW = total
work; CP_La = lactate concentration after 3-min all-out testing.
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CHAPTER FIVE: DISCUSSION
To the best of our knowledge, the present study is the first randomized, placebo
controlled investigation, conducted in a double-blind manner for supplement and a single-blind
manner for altitude, examining the additive effects of combining repeated sprint training in
hypoxia with beta-alanine supplementation on sea-level performance in recreationally-trained
men. The present study demonstrated that RSH and beta-alanine benefit performance from
different perspectives. RSH resulted in greater post-intervention values for fatigue threshold,
exercise tolerance, cardiovascular recovery and overall working capacity than RSN, while betaalanine supplementation resulted in greater anaerobic working capacity compared to placebo
following the repeated sprint training intervention.
Training Program Comparisons
The current study employed oxygen fractions of 14.2% and 20.9% for hypoxia and
normoxia, respectively. We observed that SpO2 was significantly lower in the hypoxia groups
than in the normoxia groups. This is in agreement with previous studies (Billaut et al., 2013;
Girard et al., 2016; Morrison et al., 2015), which reported that SpO2 was significantly lower in
hypoxia during an acute repeated sprint training session. Generally, lower SpO2 indicates a
reduction in O2 availability at the cellular level, particularly during recovery. Therefore, reduced
SpO2 values are usually accompanied by increased heart rate, minute ventilation and oxygen debt
(Bowtell et al., 2014). Previous training studies have consistently reported lower SpO2 when
exercising in hypoxia throughout the training period (Brocherie et al., 2015a; Faiss et al., 2015b;
Goods, Dawson, Landers, Gore, & Peeling, 2015; Hamlin et al., 2017; Kasai et al., 2015).
Similar to previous investigations (Bowtell et al., 2014), the present study also observed a greater
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SpO2 decline in hypoxia than normoxia. A greater SpO2 desaturation has been shown to induce
greater metabolic perturbations and performance declines during repeated-effort, short-duration
exercise interspersed with incomplete recoveries (Smith & Billaut, 2010, 2012). Decreased
repeated high intensity efforts have been reported in rugby athletes at relatively low altitudes
(1,550 – 1,700m) (Hamlin, Hinckson, Wood, & Hopkins, 2008; Weston, Mackenzie, Tufts, &
Mars, 2001). Smith and colleagues (2010, 2012) reported that arterial hypoxemia inhibited prefrontal cortex oxygenation during repeated sprint training and resulted in restricted muscle
recruitment and performance.
Graded Exercise Testing Performance
Greater post-intervention values for VO2max and PPO were noted in all groups, without
any between-group differences. However, a trend (p = 0.059) for a main effect for altitude was
observed for VO2max. Results from previous studies have reported contradictory findings. Millet
et al. (2014) reported elevated PPO with training regardless of altitude, while VO2max did not
improve after training at either altitude or sea-level. Kasai et al. (2015) also reported that
VO2max did not improve significantly in either RSH or RSN. Conflicting results have also been
shown for field-based tests. No significant improvements were noted in an incremental field test
for either RSH or RSN (Brocherie et al., 2015a). The investigators suggested that the total
duration of hypoxic exposure was too short to induce any positive hematological adaptations.
The present study demonstrated no changes in hemoglobin and hematocrit values in any group
regardless of intervention.
Hamlin et al. (2017) reported no substantial between group changes in YYIR, which is
consistent with some studies (Faiss et al., 2015b; Gatterer et al., 2014; Goods et al., 2015)., but
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contrasts with others (Galvin et al., 2013). The variation in aerobic adaptation between studies is
likely due to the training status of the participants. Untrained individuals are more likely to
benefit from RSH than well-trained individuals. The current results indicated a greater postintervention values for VO2RCP and PRCP following training at altitude than the groups training
in normoxia. It is generally believed that RCP demarcates heavy and severe exercise domain
(Whipp, Ward, & Rossiter, 2005), and relies on the accumulation of metabolic by-products
signaled by exercise induced lactic acidosis and hyperventilation (Meyer, Faude, Scharhag,
Urhausen, & Kindermann, 2004). Therefore, our results indicated that participants were able to
better maintain steady-state VO2 and lactate at high intensity exercise following four weeks of
RSH compared to RSN.
Repeated Sprint Testing Performance
Results of this study indicated significant improvements in RST_AP5, but not RST_AP
when exercising at altitude compared to the groups training in normoxia. Previously reported
changes in repeated sprint performance after RSH and RSN are inconsistent. Our results are
supported by several previously published investigations that showed beneficial changes in
repeated sprint performance after RSH compared to RSN (Faiss et al., 2013b; Faiss et al., 2015b;
Galvin et al., 2013; Gatterer et al., 2015; Gatterer et al., 2014; Kasai et al., 2015; Trincat et al.,
2016). However, others reported no advantage of RSH over RSN (Goods et al., 2015; Montero &
Lundby, 2016). Investigations by Brocherie et al. (2015b) and Hamlin et al. (2017) both
indicated a residual effect for repeated sprint performance in RSH, but not RSN.
Recently, there has been considerable debate over performance improvement associated
with RSH (Faiss, Holmberg, & Millet, 2015a; Lundby & Robach, 2016; Millet et al., 2017;
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Montero & Lundby, 2015). Methodological differences, including but not limited to the training
status of the participants, the selection and sequence of performance testing, and the calculation
of fatigue scores may contribute to this variation in performance change. We did not observe any
ergogenic effects for beta-alanine, which appears to confirm previous findings (Saunders et al.,
2014; Sweeney et al., 2010). It is possible that training-based performance enhancement may
have masked any potential ergogenic effects from beta-alanine supplementation. The lower limit
of 95% confidence intervals far surpassed the adjusted pre-test values for RST_AP and
RST_AP5, indicating the efficacy of the repeated sprint training itself. In support of this notion,
Bishop, Edge, and Goodman (2004) previously reported that repeated sprint ability was
significantly correlated with muscle buffering capacity measured from ∆[La-]/∆pH, but not from
titration method. Their results suggested that non-physiochemical buffering such as metabolic
reactions that consume H+ may have a greater influence on muscle buffering capacity than
physiochemical buffering, which would be provided by augmented carnosine concentrations.
Additionally, the recovery time (60 seconds) utilized during our repeated sprint protocol may not
have provided a sufficient stimulus to effectively challenge muscle buffering capacity.
Considering the halftime for PCr resynthesis has been reported to be about 1 minute (Bogdanis,
Nevill, Boobis, & Lakomy, 1996), it is plausible to deduce that the extended recovery time
allowed for a greater reliance on the PCr energy pathway, lessening the reliance on glycolytic
metabolism.
Heart rate recovery (HRR) refers to the rate at which heart rate declines within a certain
time frame, generally ranging between 30 seconds to 2 minutes, after the termination of physical
exercise (Daanen, Lamberts, Kallen, Jin, & Van Meeteren, 2012; Shetler et al., 2001). Reduced
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HRR was previously reported after maximal exercise, primarily due to the continued sympathetic
activation during the early stages of recovery (Kaikkonen, Rusko, & Martinmaki, 2008).
Research also showed that athletes competing in intermittent sports had faster HRR than
endurance athletes (Ostojic et al., 2010). A main effect for altitude was demonstrated for
RST_HR60 in the present study with the two groups training in hypoxia showing a significantly
lower post-intervention values for heart rate during recovery than those training in normoxia. It
has been suggested before that HRR can be used to predict changes in training status, as well as
to monitor the accumulation of fatigue (Daanen et al., 2012). Results of the current investigation
indicated a beneficial effect of RSH that may have facilitated physiological adaptations from
repeated sprint training and reduced the accretion of fatigue during repeated sprint testing.
3-Min All-Out Testing Performance
Critical power is considered to represent the highest sustainable rate of oxidative
metabolism (Jones, Vanhatalo, Burnley, Morton, & Poole, 2010). Commonly used to demarcate
different exercise intensity domains (Francis, Quinn, Amann, & LaRoche, 2010), critical power
has been shown to effectively track changes in aerobic capacity before and after high intensity
intermittent training (Wang et al., 2017). Our results indicated that critical power improved in all
groups, with a trend (p = 0.051) towards a main effect of altitude. Theoretically, the fatigue at or
above critical power is based on the interaction of anaerobic capacity, VO2max, and the VO2
slow component (Burnley & Jones, 2007), and may be related to the availability of high-energy
phosphates and cross-bridge dysfunction resulting from the accumulation of metabolites (Jones,
Wilkerson, DiMenna, Fulford, & Poole, 2008). It was hypothesized that critical power should
benefit from beta-alanine supplementation. However, our results indicated no effect of beta-
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alanine on critical power. While the underlying mechanism is still unknown and needs to be
addressed, performance improvements resulting from beta-alanine supplementation may have
been masked by repeated sprint training. The lower limit of 95% confidence intervals all
exceeded the adjusted pre-test value for CP. In addition, it has been suggested that open-end
point exercise tasks, such as time to exhaustion trials, are more sensitive to beta-alanine
supplementation (Trexler et al., 2015). The 3MT is a fixed-end point test that may be subject to
the influence of intrinsic pacing (Hinckson & Hopkins, 2005). In fact, a recent study (Abbiss,
Thompson, Lipski, Meyer, & Skorski, 2016) suggested that participants showed a more
conservative pacing strategy during duration-based cycling trials than distance-based cycling
trials, potentially masking any ergogenic potential derived from beta-alanine supplementation.
Saunders et al. (2016) suggested that exercise capacity measures, such as open-end point
exercise tasks, demonstrate a greater effect size than exercise performance measures, such as
fixed-end point exercise tasks when examining the efficacy of beta-alanine supplementation.
During the 3MT, critical power is estimated by averaging the power output during the last 30
seconds, where the slow component drives VO2 to its maximum and reflects the development of
muscular fatigue (Turner et al., 2006). It has previously been suggested that critical power, as a
reflection of exercise tolerance, is rate but not capacity-limited (Chidnok et al., 2012).
The work-time integral above critical power, termed AWC (or W’), theoretically
represents the maximum amount of work that can be performed above critical power (Fukuba et
al., 2003). A closer examination of our results showed that the post-intervention values for AWC
in the beta-alanine groups were significantly higher than in the placebo groups. The differential
responses are likely due to a greater improvement in CP in the placebo groups. While anaerobic
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glycolysis is the major contributor to anaerobic capacity during high intensity exercise (Medbo et
al., 1988), the accumulation of H+ ions has been shown to inhibit glycolytic enzyme activity,
including phosphofructokinase (Spriet, Soderlund, Bergstrom, & Hultman, 1987). It is likely,
that elevated muscle carnosine content from beta-alanine supplementation contributes to
improved glycolytic energy production by buffering H+ ions and fostering phosphofructokinase
activity (Baguet, Koppo, Pottier, & Derave, 2010). When comparing 95% confidence interval of
post-test values with the adjusted pre-test value, AWC appeared to be maintained in the two
beta-alanine groups, and potentially decreased in the normoxic placebo group. Our finding is not
consistent with Bellinger and Minahan (2016a), who reported an increased anaerobic capacity
from an open-end point task following beta-alanine supplementation when compared with
placebo. The underlying mechanism for this inconsistency is unknown and should be addressed
in future studies.
The utility of the ratio between AWC and CP has been previously discussed (Jones et al.,
2010). This ratio indicates the proportion of anaerobic and aerobic contribution to total work, and
originated from a two-component mathematical model examining bioenergetics (Jones et al.,
2010). Calculating this ratio from the mean raw data values provided in Table 7 revealed that it
remained unchanged in the normoxic beta-alanine group, but decreased in the placebo groups.
Our results indicated that the repeated sprint training protocol utilized may have caused a
disproportionate reliance on the aerobic energy supply yielding a potential deficit in the
anaerobic energy supply; however, beta-alanine supplementation may have alleviated or offset
this effect. This finding may have important implications for intermittent team sports like rugby,
which tend to prioritize anaerobic capacity.

48

In agreement with the VO2RCP and PRCP results from the graded exercise test, a main
effect for altitude was demonstrated when examining the total work completed during the 3MT.
The hypoxia groups had greater post-intervention values in total work than the normoxia groups.
Interestingly, Faiss et al. (2013b) reported no differences in average power from 3MT following
RSH and RSN. Since the time duration is fixed for 3MT, the lack of differences in average
power reported would be synonymous with total work as reported in the current investigation.
The discrepancy is likely due to the variation in 3MT protocol, which was not reported in detail
in their study (Faiss et al., 2013b).
No difference was noted in the lactate response between groups. Previous studies
reported conflicting results, with some reporting that beta-alanine supplementation increased
lactate level after exercise (Bellinger & Minahan, 2016a, 2016b; de Andrade Kratz et al., 2016),
while others reported no effect on post-exercise lactate concentration (Ducker et al., 2013;
Saunders et al., 2012). Blood lactate concentration is the result of lactate production and
removal, therefore it does not necessarily reflect muscle acidosis (Moxnes & Sandbakk, 2012).
Previous investigations have reported that beta-alanine supplementation can significantly reduce
exercise-induced acidosis without affecting blood lactate concentrations. The increased lactate
production following beta-alanine supplementation might be attributable to a lower
intramuscular H+ concentration, allowing for a less inhibited glycolytic metabolism and higher
rate of glycogen usage (Tobias et al., 2013). It has been suggested that the monocarboxylate
transporter (MCT) system is mainly responsible for lactate utilization from the circulation
(MCT1) and lactate efflux from glycolytic-dependent tissues (MCT4), respectively (Dimmer,
Friedrich, Lang, Deitmer, & Broer, 2000; Ullah, Davies, & Halestrap, 2006). Faiss et al. (2013b)
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demonstrated an upregulation of MCT4 mRNA and a downregulation of MCT1 mRNA in RSH,
but not RSN. Although speculative, the discrepancy between our study and previous
investigations is likely related to the differences in the ratio between MCT1 and MCT4.
However, more detailed mechanistic study is needed.
In summary, the results of this study indicate that normobaric hypoxia improved fatigue
threshold, exercise tolerance, cardiovascular recovery, and overall working capacity in
recreationally-trained men following the repeated sprint training intervention. Furthermore, it
appears that beta-alanine supplementation maintained the anaerobic working capacity following
the repeated sprint training intervention. The present study suggested that beta-alanine did not
provide additional benefits with respect to attenuating fatigue or enhancing repeated sprint
performance. However, beta-alanine supplementation maintained anaerobic working capacity,
which tended to decrease as a result of repeated sprint training, especially in normoxia.
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